ERNA - Company ID 0000748592
Eterna Therapeutics Inc. has filed 1,000 public company documents between 2010 and 2026. The most frequent type is insider trade (317 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1mo ago2026-05-20 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1mo ago2026-05-15 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1mo ago2026-05-15 | - | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 1mo ago2026-05-14 | - | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 1mo ago2026-05-14 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1mo ago2026-05-13 | - | View filing |
| ARS | Annual report to shareholders | 1mo ago2026-05-11 | 2025-12-31 | View filing |
| DEFA14A | Proxy materials | 1mo ago2026-05-11 | - | View filing |
| DEF 14A | Proxy statement | 1mo ago2026-05-11 | 2026-05-11 | View filing |
| 10-Q | Quarterly report | 1mo ago2026-05-11 | 2026-03-31 | View filing |
| 8-K | Major company event | 2mo ago2026-05-04 | 2026-05-01 | View filing |
| DEF 14C | DEF 14C | 2mo ago2026-04-13 | 2026-04-13 | View filing |
| PRE 14C | PRE 14C | 3mo ago2026-04-01 | 2026-04-01 | View filing |
| EFFECT | EFFECT | 3mo ago2026-03-30 | - | View filing |
| CORRESP | Company correspondence | 3mo ago2026-03-26 | - | View filing |
| S-3/A | S-3/A | 3mo ago2026-03-24 | - | View filing |
| 8-K | Major company event | 3mo ago2026-03-20 | 2026-03-18 | View filing |
| UPLOAD | SEC correspondence | 3mo ago2026-03-20 | - | View filing |
| S-3 | Securities registration | 3mo ago2026-03-16 | - | View filing |
| 10-K | Annual report | 3mo ago2026-03-13 | 2025-12-31 | View filing |
| 8-K | Major company event | 4mo ago2026-02-26 | 2026-02-26 | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 4mo ago2026-02-17 | - | View filing |
| 4 | Insider trade | 4mo ago2026-02-17 | 2026-02-10 | View filing |
| 8-K | Major company event | 4mo ago2026-02-11 | 2026-02-06 | View filing |
| 424B5 | Prospectus supplement | 4mo ago2026-02-10 | - | View filing |
| EFFECT | EFFECT | 5mo ago2026-02-05 | - | View filing |
| 8-A12B | 8-A12B | 5mo ago2026-02-05 | - | View filing |
| S-1/A | S-1/A | 5mo ago2026-02-05 | - | View filing |
| CERT | Exchange certification | 5mo ago2026-02-05 | - | View filing |
| S-1/A | S-1/A | 5mo ago2026-02-04 | - | View filing |
| S-1 | IPO registration | 5mo ago2026-02-03 | - | View filing |